← Product Code [FOZ](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FOZ) · K970864 # ARROW-HOWES LARGE BORE MULTI-LUMEN CENTRAL VENOUS CATHETERS (K970864) _Arrow Intl., Inc. · FOZ · Oct 17, 1997 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FOZ/K970864 ## Device Facts - **Applicant:** Arrow Intl., Inc. - **Product Code:** [FOZ](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FOZ.md) - **Decision Date:** Oct 17, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5200 - **Device Class:** Class 2 - **Review Panel:** General Hospital - **Attributes:** Therapeutic ## Indications for Use The large-bore multiple lumen catheter permits venous access to a central circulation for rapid fluid administration. It may be inserted into the jugular, subclavian, and femoral veins. The heparin coating on the catheter intended to decrease the incidence of thrombus formation associated with catheterization. ## Device Story Triple-lumen polyurethane central venous catheter (12 French); features extension lines, luer hubs, and clamps. Designed for rapid fluid administration in emergency critical care hospital settings. Inserted by clinicians into jugular, subclavian, or femoral veins. Heparin coating reduces thrombus formation. Device provides venous access; facilitates high-volume fluid delivery; enables clinical management of critical patients. ## Clinical Evidence No clinical testing was performed. Safety and effectiveness were established through bench testing, including flow rate, tensile strength, pressure leak, positive pressure burst, biocompatibility, and fatigue (flex) testing. ## Technological Characteristics 12 French triple-lumen polyurethane catheter; includes extension lines, luer hubs, and clamps. Features heparin coating. Technological characteristics are identical to predicate devices, modified for larger size and increased fluid flow rates. ## Regulatory Identification An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials. ## Predicate Devices - Arrow central venous catheters ([K820648](/device/K820648.md)) - Arrow central venous catheters ([K844080](/device/K844080.md)) - Arrow central venous catheters ([K862056](/device/K862056.md)) - Arrow central venous catheters ([K895417](/device/K895417.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} 510(k) SUMMARY - K970864 OCT 17 1997 ## Submitter: Arrow International, Inc. 2400 Bernville Road Reading, PA 19605 Contact Person: Thomas D. Nickel Vice President, Regulatory Affairs and Quality Assurance 610/478-3137 Date summary prepared - 10/16/97 ## Device: Trade Name - Arrow-Howes™ Large Bore Multi-lumen central venous catheter Common Name - Central venous catheter Classification Name - Catheter, intravascular, 80FOZ, and 21 CFR 880.5200, Intravascular catheter ## Legally marketed device to which the device is substantially equivalent: Various Arrow central venous catheters; specifically K820648, K844080, K862056, and K895417 ## Description of device: The device is a triple-lumen polyurethane catheter, 12 French in size, with three extension lines, luer hubs, and clamps. It is essentially the same in appearance and function to the Arrow multi-lumen predicate catheters except for the larger size to accommodate rapid fluid administration in emergency critical care situations in the hospital. ## Intended use of the device: The intended use and indications for use are comparable to the predicate devices, and appear below: "Indications for use: The large-bore multiple lumen catheter permits venous access to a central circulation for rapid fluid administration. It may be inserted into the jugular, subclavian, and femoral veins. The heparin coating on the catheter intended to decrease the incidence of thrombus formation associated with catheterization." {1} # Technological characteristics: The device has the same exact technological characteristics as the predicates, with the only difference being the larger size and accompanying greater fluid flow rates. The performance tests included in the submission include: 1. Flow rate 2. Tensile test 3. Pressure leak test 4. Positive pressure burst test 5. Biocompatibility tests 6. Flex (fatigue) test No clinical testing was performed. The results of the laboratory tests demonstrated that the device is safe, and as effective as the legally marketed predicate devices. 97095 {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856 OCT 17 1997 Mr. Thomas D. Nickel Vice President, Regulatory Affairs and Quality Assurance Arrow International, Incorporated 3000 Bernville Road Reading, Pennsylvania 19605 Re: K970864 Trade Name: Arrow-Howes Large Bore Multi-Lumen Central Venous Catheters Regulatory Class: II Product Code: FOZ Dated: July 21, 1997 Received: July 22, 1997 Dear Mr. Nickel: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does {3} Page 2 - Mr. Nickel not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} P.O. Box 12888 Reading, PA 19612 K 970864: Arrow-Howes™ Large Bore Multi-lumen Central Venous Catheters A RROW INTERNATIONAL 3000 Bernville Road Reading, PA 19605 (610) 378-0131 FAX: (610) 374-5360 Section 11 - Indications The large bore multiple lumen catheter permits venous access to a central circulation for rapid and administration. It may be inserted into the jugular, subclavian, or femoral veins. The heparin coating on the catheter intended to decrease the incidence of thrombus formation associated with catheterization. x Prescription Use Viola Hillard for Atheri Cricenti (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number K970864 --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FOZ/K970864](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FOZ/K970864) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com